HUP0301137A2 - Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same - Google Patents

Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same

Info

Publication number
HUP0301137A2
HUP0301137A2 HU0301137A HUP0301137A HUP0301137A2 HU P0301137 A2 HUP0301137 A2 HU P0301137A2 HU 0301137 A HU0301137 A HU 0301137A HU P0301137 A HUP0301137 A HU P0301137A HU P0301137 A2 HUP0301137 A2 HU P0301137A2
Authority
HU
Hungary
Prior art keywords
preparation
treatment
pharmaceutical composition
composition containing
same
Prior art date
Application number
HU0301137A
Other languages
Hungarian (hu)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0301137A2 publication Critical patent/HUP0301137A2/en
Publication of HUP0301137A3 publication Critical patent/HUP0301137A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

A találmány az 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin-hidrobromidra és szolvátjaira mint újgyógyszerhatóanyagra, a gyógyszerhatóanyag előállítási eljárására, agyógyszerhatóanyagot tartalmazó gyógyszerkészítményekre, valamint agyógyszerhatóanyag gyógyászati alkalmazására vonatkozik. ÓThe invention relates to 5-[4-{2-[N-methyl-N-(2-pyridyl)-amino]-ethoxy}-benzyl]-2,4-dioxo-thiazolidine hydrobromide and its solvates as a new active pharmaceutical ingredient, the preparation of the active pharmaceutical ingredient applies to its procedure, pharmaceutical preparations containing the active medicinal ingredient, and the medicinal use of the active medicinal ingredient. HE

HU0301137A 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same HUP0301137A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (2)

Publication Number Publication Date
HUP0301137A2 true HUP0301137A2 (en) 2003-08-28
HUP0301137A3 HUP0301137A3 (en) 2005-04-28

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301137A HUP0301137A3 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
EP2016076A2 (en) * 2007-01-22 2009-01-21 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
SK17142002A3 (en) 2003-10-07
OA12284A (en) 2003-11-10
HUP0301137A3 (en) 2005-04-28
JP2003535862A (en) 2003-12-02
BR0111536A (en) 2003-07-01
CZ20023966A3 (en) 2003-04-16
ZA200209954B (en) 2003-10-10
MXPA02012100A (en) 2003-04-25
PL360592A1 (en) 2004-09-20
KR20030007918A (en) 2003-01-23
BG107357A (en) 2003-08-29
DZ3382A1 (en) 2001-12-13
EP1296980A1 (en) 2003-04-02
CA2411065A1 (en) 2001-12-13
WO2001094344A1 (en) 2001-12-13
GB0014006D0 (en) 2000-08-02
NO20025883D0 (en) 2002-12-06
MA25753A1 (en) 2003-04-01
AP2002002673A0 (en) 2002-12-31
NO20025883L (en) 2003-02-03
CN1443186A (en) 2003-09-17
EA200300005A1 (en) 2003-04-24
IL153279A0 (en) 2003-07-06
AU2001264078A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
HUP0204122A2 (en) Novel composition based on a thiazolidinedione and metformin and its use
DE60220055D1 (en) 4- (4-METHOXYBENZYL) -N '- (5-NITRO-1,3-THIAZOLE-2-YL) UREA AND ITS USE IN THE TREATMENT OF GLYCOGENSYNTHASEKINASE-3 (GSK3) ASSOCIATED SUFFERING
AR015894A1 (en) USE OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] TIAZOLIDIN-2,4-DIONA AND INSULIN FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINS SUCH COMPOUNDS
HUP0301137A2 (en) Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
HUP0300777A2 (en) Tartrate salt of thiazolidinedione derivative
HUP9802897A2 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
AR045230A1 (en) ORAL DOSAGE FORM INCLUDING 5- [4- [2- (N-METHYL-N- (2- PIRIDIL) -AMINO) -ETOXI] -BENCIL] -TIAZOLIDINO-2,4-DIONA AND ANOTHER ADDITIONAL ANTI-DIABETIC AGENT; PROCEDURE FOR THE PREPARATION AND USE OF 5- [4- [2- (METIL-N- (2-PIRIDIL) -AMINO) -ETOXI] - BENCIL] - TIAZOLIDINO-2,4-DIONA AND ANOTHER ANTIDIABETIC AGENT
HUP0300938A2 (en) The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
CY1105354T1 (en) A THIAZOLIDINODIONE DERIVATIVE AND ITS USE AS AN ANTI-DIABETIC
HUP0300770A2 (en) Tartrate salt of thiazolidinedione derivative
HUP0300778A2 (en) Tartrate sal of thiazolidinedione derivative
EA200101101A1 (en) NEW PHARMACEUTICAL PREPARATION
HUP0301799A2 (en) Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide for treating diabetes mellitus, process for preparation thereof and pharmaceutical composition containing the same
HUP0300724A2 (en) Tartrate salt of thiazolidinedione derivative
PT1446404E (en) EDISILATES OF ROSIGLITAZONE AND ITS USE AS ANTIDIABETICS
HUP0301188A2 (en) Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, process for their preparation and pharmaceutical compositions containing them
HUP0301199A2 (en) A dioxo-thiazolidinedione and its use as antidiabetic
DK1315721T3 (en) A thiazolidinedione derivative and its use as an antidiabetic agent
DK1448559T3 (en) 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) thiazolodin-2,4-dionbenzensulfat; process for its preparation; polymorphs i, II and III thereof; and its use as a pharmaceutically active ingredient
ECSP003434A (en) NEW COMPOUNDS

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees